How have CERO shares performed in 2024?

CERo Therapeutics' stock was trading at $4.78 at the beginning of 2024. Since then, CERO stock has decreased by 74.3% and is now trading at $1.23. View the best growth stocks for 2024 here .

How do I buy shares of CERo Therapeutics?

Shares of CERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CERO

CERo Therapeutics (CERO) Stock Price, News & Analysis

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Free CERO Stock Alerts

$1.23

-0.07 (-5.38%)

(As of 05/8/2024 ET)

Compare

Today's Range: $1.21
▼
$1.31
50-Day Range: $1.23
▼
$3.95
52-Week Range: $1.21
▼
$12.80

Volume: 66,682 shs
Average Volume: 884,715 shs
Market Capitalization: $18.11 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials Headlines SEC Filings Social Media

Get CERo Therapeutics alerts:

Ad Crypto Swap Profits

Did You Get Your Free Bitcoin Yet?

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

About CERo Therapeutics Stock (NASDAQ:CERO)

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

CERO Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CERO Stock News Headlines

April 30, 2024 | finance.yahoo.com

CERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing Attributes

March 30, 2024 | msn.com

Compare with Bloomberg Emerging Markets Large & Mid Cap Total Return Index NOK (EMTK)

May 9, 2024 | Porter & Company (Ad)

Obama’s Forever Term [exposed]

America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.

March 21, 2024 | wsj.com

CERo Therapeutics Holdings Inc.

March 17, 2024 | morningstar.com

CERo Therapeutics Holdings Inc CERO

March 11, 2024 | finance.yahoo.com

CERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML Patients

See More Headlines

Receive CERO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CERo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 5/08/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Holding & other investment offices
Sub-Industry: N/A
Current Symbol: NASDAQ:CERO
Previous Symbol: NASDAQ:CERO
CUSIP: N/A
CIK: 1870404
Web: www.cero.bio
Phone: 215-731-9450
Fax: N/A
Employees: 8
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 14,720,000
Free Float: 12,398,000
Market Cap: $18.11 million
Optionable: N/A
Beta: -0.08

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Dr. Daniel Mark Corey M.D. (Age 45)
Founder, CTO & Director
Comp: $372.69k
Mr. Brian G. Atwood (Age 71)
President, CEO & Chairman
Mr. Charles Ross Carter (Age 56)
CFO, Treasurer & Corporate Secretary
Dr. Robert Sikorski M.D. (Age 61)
Ph.D., Consultant

Key Competitors

View All Competitors

CERO Stock Analysis - Frequently Asked Questions

How have CERO shares performed in 2024?: CERo Therapeutics' stock was trading at $4.78 at the beginning of 2024. Since then, CERO stock has decreased by 74.3% and is now trading at $1.23.
View the best growth stocks for 2024 here.
How do I buy shares of CERo Therapeutics?: Shares of CERO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CERO) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial